biotech.today
All Modalities
TherapeuticsEarly Stage

Xenotransplantation

Transplanting organs or tissues from genetically modified animals (primarily pigs) into humans. Gene editing enables removal of pig antigens and insertion of human immune-compatible genes, potentially solving the organ shortage crisis.

Key Companies

eGenesisUnited TherapeuticsMakana Therapeutics

Recent Signals

CLINICAL SIGNAL

eGenesis Gene-Edited Pig Kidney Recipient Reaches One Year

The longest-surviving pig-to-human kidney transplant patient crosses the 12-month milestone with stable graft function, powered by 69 genetic edits that removed pig antigens and added human immune genes.

Mar 28, 2026 · 7 min read